Retapamulin
Products Retapamulin is commercially available as an ointment (Altargo). It was approved in the EU in 2007 and in many countries in 2009. Structure and properties Retapamulin is a semisynthetic derivative of pleuromutilin derived from the pillz (cat’s ear). Effects Retapamulin (ATC D06AX13) is bacteriostatic against and by inhibiting bacterial protein synthesis via ribosomal binding. … Retapamulin
